home / stock / mynz / mynz quote
Last: | $0.7367 |
---|---|
Change Percent: | -3.37% |
Open: | $0.7909 |
Close: | $0.7367 |
High: | $0.795 |
Low: | $0.72 |
Volume: | 169,563 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.7367 | $0.7909 | $0.7367 | $0.795 | $0.72 | 169,563 | 05-03-2024 |
$0.765101 | $0.785 | $0.765101 | $0.815 | $0.751 | 194,251 | 05-02-2024 |
$0.75 | $0.88 | $0.75 | $0.88 | $0.7352 | 138,896 | 05-01-2024 |
$0.8799 | $0.879 | $0.8799 | $0.9 | $0.867 | 45,126 | 04-30-2024 |
$0.867 | $0.8179 | $0.867 | $0.9105 | $0.79 | 347,543 | 04-29-2024 |
$0.8181 | $0.85 | $0.8181 | $0.8794 | $0.78 | 309,587 | 04-26-2024 |
$0.8568 | $1 | $0.8568 | $1.08 | $0.81 | 1,085,328 | 04-25-2024 |
$0.8987 | $0.888 | $0.8987 | $0.9 | $0.8578 | 64,814 | 04-24-2024 |
$0.869 | $0.8999 | $0.869 | $0.9278 | $0.85 | 75,878 | 04-23-2024 |
$0.8705 | $0.9 | $0.8705 | $0.94 | $0.86 | 66,374 | 04-22-2024 |
$0.905 | $0.89 | $0.905 | $0.95 | $0.88 | 62,539 | 04-19-2024 |
$0.904 | $0.92 | $0.904 | $0.94 | $0.9 | 52,049 | 04-18-2024 |
$0.9312 | $0.9 | $0.9312 | $0.975 | $0.9 | 22,575 | 04-17-2024 |
$0.9534 | $0.95 | $0.9534 | $0.98 | $0.92 | 25,860 | 04-16-2024 |
$0.98 | $1 | $0.98 | $1 | $0.95 | 57,633 | 04-15-2024 |
$0.97 | $1 | $0.97 | $1.04 | $0.97 | 77,933 | 04-12-2024 |
$1.005 | $1.03 | $1.005 | $1.04 | $0.99505 | 66,740 | 04-11-2024 |
$1.05 | $1.04 | $1.05 | $1.08 | $0.9911 | 89,478 | 04-10-2024 |
$0.99 | $1.09 | $0.99 | $1.13 | $0.99 | 103,756 | 04-09-2024 |
$1.08 | $1.0795 | $1.08 | $1.09 | $1.055 | 31,088 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
Mainz Biomed B.V. Company Name:
MYNZ Stock Symbol:
NASDAQ Market:
Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82% 690 subjects analyzed including previously unexamined and reported patients from Company’s ColoFuture and eAArl...
Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE: JNJ) a...
BERKELEY, Calif. and MAINZ, Germany, April 09, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, announced today financial results for the fisc...